Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Dec 23 2014Key Executive Will Support Adoption of biologistex(SM) Cold Chain Management Service and EVO™ Smart Containers for Temperature Sensitive Biologics
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Nov 25 2014
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Nov 17 2014Single-Use Syringes and Bulk Dispensing Bags with Sterile Dockable Tubing Offer Improved Aseptic Processing of Clinical Cells and Tissues
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Nov 13 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Nov 06 2014Conference Call and Webcast at 4:30pm Eastern Time
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Oct 30 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Oct 21 2014RoosterBio Selects BioLife Solutions CryoStor® to Commercialize Human Bone Marrow-Derived Stem CellsAdult Mesenchymal Stem Cells Demonstrate Enhanced Survival and Recovery Following Cryopreservation with CryoStor, Reducing Research Costs and Expansion Time
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Oct 14 2014HypoThermosol® and CryoStor® Embedded in Internal Cell Therapy Candidates and Numerous Mutual Customer Regenerative Medicine Applications
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Oct 06 2014Year-to-date Core Product Revenue up 27% Over 2013
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Sep 30 2014Super-insulating Shippers Transmit Payload Location and Critical Status Information to Enable Cloud-based Cold Chain Management
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Sep 23 2014President-Elect of the Society for Cryobiology and Former Cell Therapy Executive Join Leading Clinicians, Developers, and Consultants in the Biobanking, Drug Discovery, and Regenerative Medicine Markets
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Sep 08 2014
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Aug 25 2014Clinical Grade Cell and Tissue Biopreservation Media Products Enabling Commercialization of Cellular Immunotherapies and Restorative Therapies
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Aug 07 2014Conference Call and Webcast at 4:30pm Eastern Time
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Aug 04 2014Combination of CryoStor and Dry Ice Offers Alternative High Quality, More Cost-Effective Logistics to Home-Brew Freeze Media and Liquid Nitrogen Shippers
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jul 31 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jul 17 2014Company to Produce DuraGraft® Tissue Preservation Solution for Storage of Harvested Veins
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jun 16 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jun 11 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- May 19 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- May 12 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- May 08 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- May 06 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- May 05 2014
Santa Fe, NM, May 5, 2014/PRNNewswire/– SAVSU Technologies, an innovative designer and manufacturer of high performance passive storage and transport containers for temperature sensitive...
- Apr 22 2014Cold Chain Packaging & Instrumentation Services Market Could Reach $5 Billion by 2018
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Apr 21 2014Recognition Follows Successful Stock Offering and Uplisting to NASDAQ
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Apr 16 2014Proprietary Products Revenue Grew 71% Over Q1 2013
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Apr 02 2014Autologous Cells Modified with Licensed T Cell Receptor (TCR) IP from University of Pennsylvania Studied for Safety, Bioactivity, and Effectiveness to Treat Multiple Myeloma
BOTHELL, WA — April 2, 2014 —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation...
- Mar 25 2014Common Stock to Begin Trading on NASDAQ Capital Market®
BioLife Solutions, Inc. (OTCQB: BLFS) today announced that is has closed a public offering of units for gross proceeds of approximately $15.4 million at a price of $4.30 per unit, completed the...
- Mar 20 2014
BioLife Solutions, Inc. (OTCQB: BLFS) today announced the pricing of a public offering and the entry into definitive agreements with purchasers for the sale of approximately 3.6 million units for...
- Mar 10 2014Nearly 50% of Presenting Companies are BioLife Customers
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Feb 25 2014
BioLife Solutions, Inc. (OTCQB: BLFSD), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Feb 12 20142014 Corporate Goals Include Uplisting to NASDAQ Capital Market® and Conversion of All Debt
BioLife Solutions, Inc. (OTCQB: BLFSD), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jan 29 2014HypoThermosol® Effective for Collection & Storage of Whole Blood and Components
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jan 21 2014Effective January 29, 2014; Intended to Facilitate NASDAQ Listing
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jan 09 2014Leading Manufacturer of Clinical Grade Biopreservation Media for Regenerative Medicine; Revenue Has Doubled Over the Last 2 Years to $9 Million in 2013; Report Available for Download at http://www.lifesciadvisors.com/clients/biolife
NEW YORK, NY--(Marketwired - Jan 9, 2014) - LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it...
- Jan 06 201458% Year over Year Growth Driven by Increased Adoption of Proprietary Products and Contract Manufacturing Services
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Dec 16 2013Authorization to Effect Reverse Stock Split; Debt Conversion Intended to Facilitate Potential Uplisting; Transactions Planned to Position Company for Growth and Improved Liquidity
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Dec 09 2013Discosphere™ Discogenic Stem-Like Progenitor Cells Hold Potential to Regenerate New Intervertebral Disc Material for Millions of Patients
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 19 2013Proven Medtech Executives Strengthen Board Stewardship as Company Positions for High Growth and Increased Shareholder Value
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 14 2013Company Achieves First Quarter of $1MM Core Product Revenue
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 13 2013Proprietary Biopreservation Media Products for Cells and Tissues Enabling Development of Lifesaving Therapies in the Global Regenerative Medicine Industry
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Sep 23 2013Nanoparticle-Based Precision Thermal Packaging Products Provide "Life Insurance" During Shipment of Sensitive Regenerative Medicine Biologic Source Material and Manufactured Cell and Tissue Products
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and...
- Sep 03 2013Proprietary, Clinical Grade Media Could Emerge as Gold Standard for Freezing, Storing, and Shipping Source Material and Manufactured Cell Products in High Growth Regenerative Medicine Market
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and...
- Aug 22 2013BioLife Solutions HypoThermosol® Embedded in Two Intercytex Clinical Trials of Cell-Based Wound CareProprietary Dermal Fibroblast-Based Product in HypoThermosol Could Greatly Improve Treatment of a Debilitating Skin Condition and also Burn Injuries
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Aug 13 2013CryoStor® cGMP Serum-Free, Protein-Free Freeze Media Used in Launch of More than 50 New Frozen Cell Products
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Aug 12 2013Company Achieves Twelfth Quarter of Consecutive Record Revenue Driven by Core Product Revenue of $0.9 Million
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 23 2013President and Chief Scientific Officer of NeoStem Subsidiary Progenitor Cell Therapy Joins Leading Clinicians, Developers, and Consultants in the High Growth Regenerative Medicine Market
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 10 2013
London, UK, 10 July 2013 – Lombard Medical Technologies PLC (AIM:LMT), the specialist medical technology company focussed on innovative vascular products, is pleased to announce the appointment...
- Jun 25 2013CryoStor® and HypoThermosol® Enable Improved Stability and Expanded Distribution of Blood Derived Cells for Research and Clinical Use
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...